Pharmacokinetics of sulphadoxine and trimethoprim and tissue irritation caused by two sulphadoxine-trimethoprim containing products after subcutaneous administration in pre-ruminant calves | Veterinary Research, a journal on Animal Infection

Free Access

Issue		Vet. Res. Volume 31, Number 5, September-October 2000


Page(s)		517 - 526
DOI		https://doi.org/10.1051/vetres:2000137
How to cite this article		Vet. Res. (2000) 517-526

References

1: Anonymous, The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology: Recommended method for the determination of creatine kinase in blood, Scand. J. Clin. Lab. Invest. 36 (1976) 711-723.
2: Anonymous, Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard, NCCLS Document M31-A, Pennsylvania, 1999.
3: Becker W., Klatt P., Seeger K., Untersuchungen nach subkutaner und intramuskulörer Applikation von Borgal-Lösung 24% ad us. vet. beim Kalb, Tierärztl. Umsch. 42 (1987) 266-270.
4: Bishop Y. (Ed.) The Veterinary Formulary, 4th ed., Pharmaceutical Press, Great Britain, 1998.
5: Bushby S.R.M., Sulfonamide and trimethoprim combinations, J. Am. Vet. Med. Assoc. 176 (1980) 1049-1053.
6: Comereski C.R., Williams P.D., Bregman C.L., Hottendorf G.H., Pain on injection and muscle irritation: a comparison of animal models for assessing parenteral antibiotics, Fundam. Appl. Toxicol. 6 (1986) 335-338.
7: Davitiyananda D., Rasmussen F., Half-lives of sulphadoxine and trimethoprim after a single intravenous infusion in cows, Acta Vet. Scand. 15 (1974) 356-365.
8: Guard C.L., Schwark W.S., Friedman D.S., Blackshear P., Haluska M., Age-related alterations in trimethoprim-sulfadiazine disposition following oral or parenteral administration in calves, Can. J. Vet. Res. 50 (1986) 342-346.
9: Jones B., Kenward M.G., Design and Analysis of Cross-Over Trials, Chapman and Hall, London, 1990.
10: Kaartinen L., Löhönen K., Wiese B., Franklin A., Pyörälä S. Pharmacokinetics of sulphadiazine-trimethoprim in lactating dairy cows, Acta Vet. Scand. 40 (1999) 271-278.
11: Lefèbvre H.P., Braun V., Laroute V., Toutain P.L., Evaluation and mechanisms of tolerance of locally administered drugs, J. Vet. Pharmacol. Ther. 20 (Suppl. 1) (1997) 320-322.
12: Nielsen P., Rasmussen F., Concentrations of trimethoprim and sulphadoxine in tissues from goats and a cow, Acta Vet. Scand. 16 (1975) 405-410.
13: Nielsen P., Rasmussen F., Half-life, apparent volume of distribution and protein-binding for some sulphonamides in cows, Res. Vet. Sci. 22 (1977) 205-208.
14: Nielsen P., Romvary A., Rasmussen F., Sulphadoxine and trimethoprim in goats and cows: absorption fraction, half-lives and the degrading effect of the ruminal flora, J. Vet. Pharmacol. Ther. 1 (1978) 37-46.
15: Pashov, D., Mutafchieva, R., Drumev, D., Koichev, K.B., Abramova, N., Pharmacokinetics, biological availability and tissue residues of a combination of sulfadoxine and trimethoprim injected into calves, Vet. Med. Nauki 21 (1984) 84-93.
16: Piercy D.T.W., Distribution of trimethoprim/sulphadiazine in plasma, tissue and synovial fluids, Vet. Rec. 102 (1978) 523-524.
17: Plumb D.C., Veterinary drug handbook, 2nd ed., Iowa State University Press, Ames, 1995.
18: Prescott J.F., Baggot J.D. (Eds.), Antimicrobial Therapy in Veterinary Medicine, 2nd ed., Iowa State Univ. Press, Ames, 1993.
19: Pyörälä S., Manner E., Kesti E., Sandholm M., Local tissue damage in cows after intramuscular injections of eight different antimicrobial agents, Brief communication, Acta Vet. Scand. 35 (1994) 107-110.
20: Roussel A.J. Jr., Brumbaugh G.W., Treatment of diarrhea of neonatal calves, Vet. Clin. North Am. Food Anim. Pract. 7 (1991) 713-728.
21: Shoaf S.E., Schwark W.S., Guard C.L., Schwartsman R.V., Pharmacokinetics of trimethoprim/sulfadiazine in neonatal calves: influence of synovitis, J. Vet. Pharmacol. Ther. 9 (1986) 446-454.
22: Shoaf S.E., Schwark W.S., Guard C.L., The effect of age and diet on sulfadiazine/trimethoprim disposition following oral and subcutaneous administration to calves, J. Vet. Pharmacol. Ther. 10 (1987) 331-345.
23: Son D.S., Hariya S., Shimoda M., Kokue, E., Contribution of $\alpha_1$ -acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs, J. Vet. Pharmacol. Ther. 19 (1996) 170-183.
24: Steiness E., Rasmussen F., Svendsen O., Nielsen P., A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs, Acta Pharmacol. Toxicol. 42 (1978) 357-364.
25: Toutain P.L., Lassourd V., Costes G., Alvinerie M., Bret L., Lefèbvre H.P., Braun J.P., A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses, J. Vet. Pharmacol. Ther. 18 (1995) 226-235.
26: White G., Piercy D.W.T., Gibbs H.A., Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo, Res. Vet. Sci. 31 (1981) 27-31.
27: Yamaoka K., Nakagawa T., Uno T., Statistical moments in pharmacokinetics, J. Pharmacokinet. Biopharm. 6 (1978) 547-558.

Abstract